share_log

Pfizer | 8-K: Current report

Pfizer | 8-K: Current report

辉瑞 | 8-K:重大事件
美股sec公告 ·  05/22 12:44
Moomoo AI 已提取核心信息
Pfizer Inc. has announced the launch of a multi-year program aimed at reducing its cost of goods sold. The program, which will unfold over several years, is expected to focus on operational efficiencies, changes to the network structure, and product portfolio enhancements. The first phase, concentrating on operational efficiencies, is projected to yield savings of approximately $1.5 billion by the end of 2027, with some savings beginning to materialize in 2025. The estimated one-time costs to achieve these savings are about $1.7 billion, primarily for severance and implementation, and will be recorded mainly in 2024. Cash outlays are anticipated in 2025 and 2026. Pfizer cautions that these estimates are based on assumptions and actual results may vary. Additional charges or expenditures not currently anticipated may arise in connection with this program or its potential future phases. The announcement was made in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on May 22, 2024.
Pfizer Inc. has announced the launch of a multi-year program aimed at reducing its cost of goods sold. The program, which will unfold over several years, is expected to focus on operational efficiencies, changes to the network structure, and product portfolio enhancements. The first phase, concentrating on operational efficiencies, is projected to yield savings of approximately $1.5 billion by the end of 2027, with some savings beginning to materialize in 2025. The estimated one-time costs to achieve these savings are about $1.7 billion, primarily for severance and implementation, and will be recorded mainly in 2024. Cash outlays are anticipated in 2025 and 2026. Pfizer cautions that these estimates are based on assumptions and actual results may vary. Additional charges or expenditures not currently anticipated may arise in connection with this program or its potential future phases. The announcement was made in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on May 22, 2024.
辉瑞公司宣布启动一项为期多年的计划,旨在降低其商品销售成本。该计划将持续数年,预计将侧重于运营效率、网络结构变更和产品组合增强。第一阶段侧重于运营效率,预计到2027年底将节省约15亿美元,部分节省资金将在2025年开始实现。据估计,实现这些节省的一次性成本约为17亿美元,主要用于遣散和实施,并将主要在2024年入账。预计现金支出将在2025年和2026年出现。辉瑞警告说,这些估计是基于假设,实际结果可能会有所不同。该计划或其未来可能的阶段可能会产生目前未预计的额外费用或支出。该公告是在2024年5月22日向美国证券交易委员会提交的8-K表最新报告中发布的。
辉瑞公司宣布启动一项为期多年的计划,旨在降低其商品销售成本。该计划将持续数年,预计将侧重于运营效率、网络结构变更和产品组合增强。第一阶段侧重于运营效率,预计到2027年底将节省约15亿美元,部分节省资金将在2025年开始实现。据估计,实现这些节省的一次性成本约为17亿美元,主要用于遣散和实施,并将主要在2024年入账。预计现金支出将在2025年和2026年出现。辉瑞警告说,这些估计是基于假设,实际结果可能会有所不同。该计划或其未来可能的阶段可能会产生目前未预计的额外费用或支出。该公告是在2024年5月22日向美国证券交易委员会提交的8-K表最新报告中发布的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息